Funded Projects › HORIZON
PanCare4AYA · Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer
Survivors of AYA cancer are at risk of treatment-related mortality and morbidity (late effects). The impact on the quality of life (QoL) of AYA cancer survivors and their families, as well as the societal and economic burdens, is significant. However, these impacts can be prevented or reduced by long-term, systematic screening and follow-up (Survivorship Care), which enables the early detection of treatable late effects and timely interventions to preserve health, increase empowerment, manage chronic conditions and improve QoL. PanCare4AYA will improve Survivorship Care for AYA cancer survivors across Europe by developing an international clinical guideline for screening and follow-up. This guideline will be implemented via a novel person-centred screening programme (AYA Cancer Survivor Screen). An implementation study involving 1,000 AYA cancer survivors in 11 European countries (Croatia, Czech Republic, France, Germany, Italy, Lithuania, Netherlands, Norway, Sweden, Switzerland, United Kingdom) will be conducted to test the AYA Cancer Survivor Screen programme, including peer support. The study will look at effectiveness (empowerment, mental health, psychosocial functioning and other QoL-related outcomes), healthcare delivery and screening-related health, experiences of AYA cancer survivors and HCPs with implementing the state-of-the-art screening programme within a range of different healthcare settings, and feasibility. Innovative digital tools will be used in France, Italy, Lithuania and Netherlands.Ensuring the scalability of the AYA Cancer Survivor Screen programme is crucial for achieving enduring, real-world improvements to Survivorship Care for AYA cancer survivors. Therefore, the project includes the assessment of barriers and facilitators for the screening programme and development of freely available materials to support sustainable maintenance and scale-up of AYA Cancer Survivor Screen in additional clinics in future.This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA)”.
Consortium · 31 organisations
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
NL · €832,578
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG
NL · €229,375
PANCARE
NL · €199,531
PINTAIL LTD
IE · €398,750
ISTITUTO GIANNINA GASLINI
IT · €225,625
NACIONALINIS VEZIO INSTITUTAS
LT
EUROPEAN CANCER ORGANISATION
BE · €275,000
UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN
DE
ACADEMISCH ZIEKENHUIS GRONINGEN
NL · €287,500
FAKULTNI NEMOCNICE BRNO
CZ · €203,125
OSLO UNIVERSITETSSYKEHUS HF
NO · €202,500
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
NL · €155,625
UNIVERSITAET LEIPZIG
DE · €240,000
GCS HOPITAUX UNIVERSITAIRES GRAND OUEST
FR · €421,250
UNIVERSITY OF LEEDS
UK · €196,250
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
NL · €320,625
CHILDHOOD CANCER INTERNATIONAL
NL · €277,188
UNIVERSITETET I OSLO
NO · €48,125
VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS
LT · €186,563
KLINIKA ZA DJECJE BOLESTI ZAGREB
HR · €102,500
DATARIVER SRL
IT · €207,500
CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS
FR
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ
DE · €107,500
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS
IT · €205,000
REGION STOCKHOLM
SE · €345,000
SIOP EUROPE
BE · €103,125
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE BREST
FR
Stiftung Ostschweizer Kinderspital
CH
UNIVERSITAET zu LUEBECK
DE
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES
FR
CHU COTE DE NACRE - CAEN
FR
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.